Clearity Care, building on Amsterdam UMC research, combines micro-CT scanning and genetic testing of miscarriage tissue — and from January 2027 it will be available nationwide, Trouw reported.
That is a break with current practice. Under European Society of Human Reproduction and Embryology (ESHRE) guidance, which the Dutch gynecologists’ association NVOG follows, miscarriage tissue is generally not examined. De Bakker told Trouw she believes the guidance is driven partly by cost, noting that there are certainly also colleagues who consider it too expensive care.
Her pilot data, she told Trouw, points the other way. She says she can identify a cause in roughly three-quarters of miscarriages: an anatomical abnormality in 71 percent of embryos and fetuses scanned, and a genetic diagnosis in 50 to 75 percent of cases.
Clearity Care Examines Lost Pregnancy Directly
- Clearity Care examines the lost pregnancy directly: a micro-CT scan, genetic testing, and a finger-prick blood sample from each parent to compare the embryo’s DNA against theirs.
Seven Years of Fighting for a 7,000-Kilo Scanner
A standard CT or MRI cannot resolve an embryo, with de Bakker telling Trouw that you just don’t see it, that’s one pixel. Micro-CT, developed by her team over years, reaches a resolution at which even the cranial nerves are visible.
She expressed gratitude that the scanner is not sitting in a basement somewhere, but in the heart of patient care, where this care belongs.
The clinical baseline it depends on came from the Fetal Biobank she co-founded at Amsterdam UMC in 2017, collecting donated tissue from ectopic pregnancies, preterm births, and pregnancy terminations, explaining that strangely enough they didn’t really know how a healthy embryo develops. Millions of ultrasound scans are performed worldwide, she noted, yet normal development was poorly mapped. Once you know what normal looks like, you can see what deviates.
Five Miscarriages, and One Question That Stayed Open
De Bakker’s push is personal as well as scientific. In 2019, ten weeks pregnant with her third child, she finished a presentation to gynecologists on embryonic development while bleeding heavily — she knew the baby inside her had died. She has since had five miscarriages in total, including one after seeing a heartbeat on ultrasound. Her fourth child was born after them.
What she remembers most sharply is the isolation: no midwife, no hospital bed, no partner leave, alone in the bathroom with heavy bleeding.
The Data Behind the Case for Testing
The psychological stakes are documented. Research by Jessica Farren, cited by de Bakker in Trouw, found that nine months after a miscarriage, 18 percent of mothers have post-traumatic stress disorder and 6 percent have depression.
| Measure | Figure | Source |
|---|---|---|
| Parents who want to know the cause | 86% | De Bakker’s international survey, via Trouw |
| Parents never told a possible cause | 80% | De Bakker’s international survey, via Trouw |
| Mothers with PTSD nine months after loss | 18% | Jessica Farren’s research, cited in Trouw |
| Mothers with depression nine months after loss | 6% | Jessica Farren’s research, cited in Trouw |
| Cases with anatomical abnormality found | 71% | De Bakker’s pilot data, via Trouw |
| Genetic analysis yielding a diagnosis | 50–75% | De Bakker’s pilot data, via Trouw |
She believes diagnosis reduces misplaced guilt, uncertainty, and fear of recurrence — but she frames that as a hypothesis she still wants to test, partly to win over insurers.
She thinks that it can reduce misplaced feelings of guilt, uncertainty, and fear of recurrence.
Why She Skipped the Academic Route
De Bakker could have spent another decade in peer-reviewed validation before offering anything to patients. She chose a company instead. "I want it now," she told Trouw.
She insists the 595-euro fee must not create a two-tier system.
Report Is Not a Substitute for Psychological Care
- De Bakker herself stresses that a report is not a substitute for psychological care.
The Question Still Open
Whether clearer answers actually ease the psychological burden — and whether insurers will pay for proving it — remains untested. That evidence, not the scanner, is now what decides whether this reaches every parent in the Netherlands or stays a 595-euro option. As de Bakker noted in Trouw, not everyone experiences a miscarriage as ‘bad luck.’
References
- Trouw — interview and report on embryologist Bernadette de Bakker and the launch of Clearity Care (source of all quotations and pilot figures in this article).
- European Society of Human Reproduction and Embryology (ESHRE) — recurrent pregnancy loss guidelines, as cited in Trouw.
- Dutch Society of Obstetrics and Gynecology (NVOG) — current national practice guidance on miscarriage investigation, as cited in Trouw.
- Farren, J. et al. — research on post-traumatic stress and depression after miscarriage, as cited in Trouw.
- Amsterdam UMC — Fetal Biobank (est. 2017) and micro-CT imaging program, as reported in Trouw.